This book deals with how pharmacogenomics informs personalized drug dosing strategies. It covers genetic markers that dictate optimal dosages to maximize efficacy and minimize toxicity. The text emphasizes individualized treatment plans based on genetic profiles to enhance therapeutic outcomes. Designed for clinicians and pharmacogenomic specialists, it promotes precision dosing in various therapeutic areas.
Patrick Richardson specializes in pharmacogenomics to personalize drug dosing in dermatological treatments, ensuring optimal efficacy and safety. His research explores how genetic variations affect the metabolism and response to medications used for skin conditions like psoriasis and eczema. Patrick has authored numerous studies on developing personalized dosing regimens based on pharmacogenomic data to enhance treatment outcomes. He also offers guidelines for clinicians to incorporate pharmacogenomic insights into drug dosing decisions, promoting personalized and effective dermatological care through tailored pharmacotherapy.